This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Snook, Adam
Item Type | Name |
Concept
|
Immunotherapy
|
Concept
|
Immunotherapy, Adoptive
|
Academic Article
|
GUCY2C-targeted cancer immunotherapy: past, present and future.
|
Academic Article
|
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
|
Academic Article
|
Advances in cancer immunotherapy.
|
Academic Article
|
Colorectal cancer immunotherapy.
|
Academic Article
|
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
|
Academic Article
|
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
|
Academic Article
|
Could targeting T-helper cells aid the development of effective cancer vaccines?
|
Academic Article
|
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.
|
Academic Article
|
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
|
Academic Article
|
Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.
|
Academic Article
|
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
|
Academic Article
|
Immunotherapy regimens for metastatic colorectal carcinomas.
|
Academic Article
|
The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report.
|
Academic Article
|
The swinging pendulum of cancer immunotherapy personalization.
|
Academic Article
|
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.
|
Academic Article
|
Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
|
Academic Article
|
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
|
Academic Article
|
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers.
|
Academic Article
|
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment.
|
Academic Article
|
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMBÂ and PD-L1.
|
Academic Article
|
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
|
Academic Article
|
The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance.
|
Academic Article
|
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.
|